Related references
Note: Only part of the references are listed.Healthcare Costs Related to Treatment of Hepatocellular Carcinoma Among Veterans With Cirrhosis in the United States
David E. Kaplan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Radioembolization for hepatocellular carcinoma: Statistical confirmation of improved survival in responders by landmark analyses
Ahsun Riaz et al.
HEPATOLOGY (2018)
SBRT for Hepatocellular Carcinoma: 8-Year Experience from a Regional Transplant Center
Haoming Qiu et al.
JOURNAL OF GASTROINTESTINAL CANCER (2018)
Prognostic scores for sorafenib-treated hepatocellular carcinoma patients: A new application for the hepatoma arterial embolisation prognostic score
J. Edeline et al.
EUROPEAN JOURNAL OF CANCER (2017)
Role of Stereotactic Body Radiation Therapy Before Orthotopic Liver Transplantation: Retrospective Evaluation of Pathologic Response and Outcomes
Edward Michael Mannina et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Predictors of Liver Toxicity Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
Michael Velec et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Trends in the Mortality of Hepatocellular Carcinoma in the United States
Eliza W. Beal et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2017)
Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis
Gonzalo Sapisochin et al.
JOURNAL OF HEPATOLOGY (2017)
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B. El-Khoueiry et al.
LANCET (2017)
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
Valerie Vilgrain et al.
LANCET ONCOLOGY (2017)
Systematic review of patient reported quality of life following stereotactic ablative radiotherapy for primary and metastatic liver cancer
Adam Mutsaers et al.
RADIATION ONCOLOGY (2017)
Cost-effectiveness of Stereotactic Body Radiation Therapy versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Markov Modeling Study
Erqi L. Pollom et al.
RADIOLOGY (2017)
Normal Tissue Constraints for Abdominal and Thoracic Stereotactic Body Radiotherapy
Erqi L. Pollom et al.
SEMINARS IN RADIATION ONCOLOGY (2017)
Cost-effectiveness analysis of potentially curative and combination treatments for hepatocellular carcinoma with person-level data in a Canadian setting
Hla-Hla Thein et al.
CANCER MEDICINE (2017)
Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications
Atsushi Hiraoka et al.
LIVER CANCER (2017)
Tumor response assessment by MRI following stereotactic body radiation therapy for hepatocellular carcinoma
Guillaume Oldrini et al.
PLOS ONE (2017)
Cost-effectiveness analysis of treatment with non-curative or palliative intent for hepatocellular carcinoma in the real-world setting
Hla-Hla Thein et al.
PLOS ONE (2017)
Radioembolisation of hepatocellular carcinoma: a primer
N. Venkatanarasimha et al.
CLINICAL RADIOLOGY (2017)
Triphasic contrast enhanced CT simulation with bolus tracking for pancreas SBRT target delineation
Devon J. Godfrey et al.
PRACTICAL RADIATION ONCOLOGY (2017)
Progressive Hypofractionated Carbon-Ion Radiotherapy for Hepatocellular Carcinoma: Combined Analyses of 2 Prospective Trials
Goro Kasuya et al.
CANCER (2017)
Stereotactic ablative radiotherapy for adrenal gland metastases: Factors influencing outcomes, patterns of failure, and dosimetric thresholds for toxicity
William W. Chance et al.
PRACTICAL RADIATION ONCOLOGY (2017)
Assessment of hepatic function decline after stereotactic body radiation therapy for primary liver cancer
Diego A. S. Toesca et al.
PRACTICAL RADIATION ONCOLOGY (2017)
Stereotactic body radiation therapy for small primary or recurrent hepatocellular carcinoma in 132 Chinese patients
Ting-Shi Su et al.
JOURNAL OF SURGICAL ONCOLOGY (2016)
Pretreatment quality of life as a prognostic factor for early survival and functional outcomes in patients with head and neck cancer
Chan Joo Yang et al.
QUALITY OF LIFE RESEARCH (2016)
Single administration of Selective Internal Radiation Therapy versus continuous treatment with sorafeNIB in locally advanced hepatocellular carcinoma (SIRveNIB): study protocol for a phase iii randomized controlled trial
Mihir Gandhi et al.
BMC CANCER (2016)
Phase 2 study of stereotactic body radiotherapy and optional transarterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablation
Atsuya Takeda et al.
CANCER (2016)
Unresectable Hepatocellular Carcinoma: Radioembolization Versus Chemoembolization: A Systematic Review and Meta-analysis
Laila Lobo et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2016)
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
Riad Salem et al.
GASTROENTEROLOGY (2016)
Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response
Norah A. Terrault et al.
GASTROENTEROLOGY (2016)
Phase 1 Trial of Sorafenib and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
Anthony M. Brade et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
Theodore S. Hong et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma
Daniel R. Wahl et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Comparison of survival, safety, and efficacy after transarterial chemoembolization and radioembolization of Barcelona Clinic Liver Cancer stage B-C hepatocellular cancer patients
Cigdem Soydal et al.
NUCLEAR MEDICINE COMMUNICATIONS (2016)
Cost-effectiveness of sorafenib versus SBRT for unresectable advanced hepatocellular carcinoma
Henry W. C. Leung et al.
RADIATION ONCOLOGY (2016)
Stereotactic body radiotherapy for primary hepatic malignancies - Report of a phase I/II institutional study
Ashley A. Weiner et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma
Pei-Pei Song et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Prospective Longitudinal Assessment of Quality of Life for Liver Cancer Patients Treated With Stereotactic Body Radiation Therapy
Jonathan Klein et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT)
Marta Scorsetti et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2015)
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach-The ALBI Grade
Philip J. Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma
Hideomi Yamashita et al.
JOURNAL OF RADIATION RESEARCH (2015)
Stereotactic body radiation therapy as an ablative treatment for inoperable hepatocellular carcinoma
Andres Huertas et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Transarterial Y90 radioembolization versus chemoembolization for patients with hepatocellular carcinoma: A meta-analysis
Yafei Zhang et al.
BIOSCIENCE TRENDS (2015)
Influence of liver toxicities on prognosis after stereotactic body radiation therapy for hepatocellular carcinoma
Naoko Sanuki et al.
HEPATOLOGY RESEARCH (2015)
Treatment variables related to liver toxicity in patients with hepatocellular carcinoma, Child-Pugh class A and B enrolled in a phase 1-2 trial of stereotactic body radiation therapy
Foster D. Lasley et al.
PRACTICAL RADIATION ONCOLOGY (2015)
Effect of high-dose stereotactic body radiation therapy on liver function in the treatment of primary and metastatic liver malignancies using the Child-Pugh score classification system
Pawel Dyk et al.
PRACTICAL RADIATION ONCOLOGY (2015)
Stereotactic body radiotherapy for small hepatocellular carcinoma: A retrospective outcome analysis in 185 patients
Naoko Sanuki et al.
ACTA ONCOLOGICA (2014)
Assessment of response to therapy in hepatocellular carcinoma
Tushar Patel et al.
ANNALS OF MEDICINE (2014)
Quality of life after the initial treatments of non-small cell lung cancer: a persistent predictor for patients' survival
Irawati Lemonnier et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2014)
Radiologic Versus Pathologic Assessment of Response in Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy
E. M. Mannina et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Stereotactic ablative body radiotherapy for previously untreated solitary hepatocellular carcinoma
Atsuya Takeda et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
Kris V. Kowdley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Feasibility of stereotactic body radiation therapy with volumetric modulated arc therapy and high intensity photon beams for hepatocellular carcinoma patients
Po-Ming Wang et al.
RADIATION ONCOLOGY (2014)
The efficacy of stereotactic body radiation therapy on huge hepatocellular carcinoma unsuitable for other local modalities
Jenny Y. Que et al.
RADIATION ONCOLOGY (2014)
Outcomes following definitive stereotactic body radiotherapy for patients with Child-Pugh B or C hepatocellular carcinoma
Shaelyn Culleton et al.
RADIOTHERAPY AND ONCOLOGY (2014)
Stereotactic body radiotherapy combined with transarterial chemoembolization for huge (≥10 cm) hepatocellular carcinomas: A clinical study
Nan Bao Zhong et al.
MOLECULAR AND CLINICAL ONCOLOGY (2014)
Stereotactic body radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombosis
Jingbo Kang et al.
MOLECULAR AND CLINICAL ONCOLOGY (2014)
Health Care Costs Associated With Hepatocellular Carcinoma: A Population-Based Study
Hla-Hla Thein et al.
HEPATOLOGY (2013)
Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma
Alexis Bujold et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Stereotactic body radiation therapy combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma
Yohji Honda et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Effectiveness of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma with Portal Vein and/or Inferior Vena Cava Tumor Thrombosis
Mian Xi et al.
PLOS ONE (2013)
High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma
Won Il Jang et al.
RADIATION ONCOLOGY (2013)
Evaluation of response after stereotactic body radiotherapy for hepatocellular carcinoma
Tracy R. Price et al.
CANCER (2012)
Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization
Jin-Kyu Kang et al.
CANCER (2012)
Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation
John K. O'Connor et al.
LIVER TRANSPLANTATION (2012)
The Safety and Efficacy of High-Dose Proton Beam Radiotherapy for Hepatocellular Carcinoma: A Phase 2 Prospective Trial
David A. Bush et al.
CANCER (2011)
Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma
Higinia R. Cardenes et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2010)
Radiologic-Pathologic Correlation of Hepatocellular Carcinoma Treated with Internal Radiation Using Yttrium-90 Microspheres
Absun Riaz et al.
HEPATOLOGY (2009)
A PROSPECTIVE STUDY OF HYPOFRACTIONATED PROTON BEAM THERAPY FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA
Nobuyoshi Fukumitsu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
DESCRIPTIVE ANALYSIS OF OLIGOMETASTATIC LESIONS TREATED WITH CURATIVE-INTENT STEREOTACTIC BODY RADIOTHERAPY
Michael T. Milano et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma
Regina V. Tse et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Safety and efficacy of Y-90 radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis
Laura M. Kulik et al.
HEPATOLOGY (2008)
Partial volume tolerance of the liver to radiation
LA Dawson et al.
SEMINARS IN RADIATION ONCOLOGY (2005)
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
G Fattovich et al.
GASTROENTEROLOGY (2004)
The utility of marginal donors in liver transplantation
RW Busuttil et al.
LIVER TRANSPLANTATION (2003)
Analysis of radiation-induced liver disease using the Lyman NTCP model
LA Dawson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:: a randomised controlled trial
JM Llovet et al.
LANCET (2002)
Share Paper
